-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GRC-54276 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GRC-54276 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GRC-54276 in Breast Cancer Drug Details: GRC-54276 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GRC-54276 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GRC-54276 in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GRC-54276 in Ovarian Cancer Drug Details: GRC-54276 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GRC-54276 in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GRC-54276 in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GRC-54276 in Cervical Cancer Drug Details: GRC-54276 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GRC-54276 in Colon Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GRC-54276 in Colon Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GRC-54276 in Colon Cancer Drug Details: GRC-54276 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-22P in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-22P in Solid Tumor report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3537021 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3537021 in Type 2 Diabetes report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Omalizumab Biosimilar in Allergic Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Omalizumab Biosimilar in Allergic Asthma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Omalizumab biosimilar in Allergic Asthma Drug Details: Omalizumab biosimilar (GBR-310)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efinopegdutide in Non Alcoholic Fatty Liver Disease (NAFLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efinopegdutide in Non Alcoholic Fatty Liver Disease (NAFLD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Efinopegdutide in Non Alcoholic Fatty Liver Disease (NAFLD)Drug Details:...
-
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment ·      Nasal ·      Vaginal ·      Buccal Delivery ·      Rectal Key Territories ·      The US...
-
Company Profile
Glenmark Pharmaceuticals Ltd – Company Profile
Glenmark Pharmaceuticals Ltd (Glenmark) focuses on the discovery and development of new chemical entities (NCEs). It develops and markets branded and generic formulations. The company's formulations business encompasses therapeutic areas such as dermatology, respiratory, and oncology. The company also has presence in other therapeutic areas such as diabetes, cardiovascular and oral contraceptives. The company manufactures and supplies active pharmaceutical ingredients (APIs). Glenmark has manufacturing facilities in India, Argentina, the US and Czech Republic. The company markets its products in North...
Add to Basket